Alternate Health USA Inc. v. Paul Edalat

CourtDistrict Court, C.D. California
DecidedMarch 14, 2022
Docket8:17-cv-01887
StatusUnknown

This text of Alternate Health USA Inc. v. Paul Edalat (Alternate Health USA Inc. v. Paul Edalat) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Alternate Health USA Inc. v. Paul Edalat, (C.D. Cal. 2022).

Opinion

Case 8:17-cv-01887-JWH-JDE Document 215 Filed 03/14/22 Page 1 of 27 Page ID #:3763

1 O 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 FOR THE CENTRAL DISTRICT OF CALIFORNIA 10 11 ALTERNATE HEALTH USA INC.; Case No. 8:17-cv-01887-JWH-JDEx ALTERNATE HEALTH CORP.; and 12 ALTERNATE HEALTH, INC., MEMORANDUM OPINION AND 13 Plaintiffs, ORDER ON MOTION OF COUNTERDEFENDANT 14 v. COMPUTERSHARE INVESTOR SERVICES INC. TO DISMISS 15 PAUL EDALAT; SEVERED CLAIMS FOR FORUM OLIVIA KARPINSKI; NON CONVENIENS AND IN THE 16 FARAH BARGHI; INTEREST OF INTERNATIONAL EFT GLOBAL HOLDINGS, INC. COMITY [ECF No. 208] AND 17 D/B/A SENTAR MOTION OF ALL OTHER PHARMACEUTICALS; and PARTIES TO DISMISS THEIR 18 APS HEALTH SCIENCES, INC., CLAIMS AGAINST EACH OTHER [ECF No. 191] 19 Defendants.

20 PAUL EDALAT; EFT GLOBAL HOLDINGS, INC. dba 21 SENTAR PHARMACEUTICALS; FARAH BARGHI; and OLIVIA 22 KARPINSKI, on behalf of themselves and derivatively on 23 behalf of ALTERNATE HEALTH USA INC. and ALTERNATE 24 HEALTH CORP.,

25 Counterclaimants,

26 v.

27 ALTERNATE HEALTH USA INC., ALTERNATE HEALTH CORP., 28 ALTERNATE HEALTH, INC., Case 8:17-cv-01887-JWH-JDE Document 215 Filed 03/14/22 Page 2 of 27 Page ID #:3764

1 HOWARD MANN, MICHAEL L. MURPHY, M.D., and 2 COMPUTERSHARE INVESTOR SERVICES, INC., 3 Counterdefendants. 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 Case 8:17-cv-01887-JWH-JDE Document 215 Filed 03/14/22 Page 3 of 27 Page ID #:3765

1 This case boasts a voluminous and intricate procedural history. But it 2 nearly resolved itself neatly on the eve of trial when most of the parties jointly 3 moved to dismiss all claims between them pursuant to Rule 41(a)(2) of the 4 Federal Rules of Civil Procedure.1 5 However, a slight wrinkle emerged. That settlement and proposed 6 dismissal left out Counterdefendant Computershare Investor Services Inc. 7 (“Computershare”) and two of nine counterclaims that the Edalat 8 Counterclaimants asserted against Computershare under Canadian law.2 9 Accordingly, the Court severed those two counterclaims from the rest of the 10 case and permitted a limited amount of discovery.3 11 Computershare now moves to dismiss those Canadian-law counterclaims 12 on the grounds of forum non conveniens and the principles of international 13 comity.4 The Computershare Motion presents the question of whether this 14 Court is a proper forum for Computershare and the Edalat Counterclaimants to 15 adjudicate those claims. The Edalat Counterclaimants urge this Court to keep 16 those claims; Computershare argues that this Court should not. After 17 considering the papers filed in support and in opposition,5 both Motions before 18 the Court are GRANTED, as explained herein. 19

20 1 See generally Joint Mot. to Dismiss (the “Joint Motion”) [ECF No. 191]. The moving parties are Plaintiffs and Counterdefendants Alternate Health USA, 21 Inc.; Alternate Health Corp.; and Alternate Health, Inc. and Counterdefendants Howard Mann and Michael Murphy (collectively, the “Alternate Health 22 Parties”), on the one hand, and Defendants and Counterclaimants Paul Edalat; EFT Global Holdings Inc. d/b/a Sentar Pharmaceuticals (“Sentar”); Olivia 23 Karpinski; Farah Barghi; (collectively, the “Edalat Counterclaimants”) and Defendant APS Health Sciences, Inc. (“APS”) (collectively with the Edalat 24 Counterclaimants, the “Edalat Parties”), on the other hand. 2 See Fourth Am. Counterclaim (“FACC”) [ECF No. 97] ¶¶ 83-95. 25 3 Order on Joint Motion (“Order on Joint Motion”) [ECF No. 207] 3. 26 4 See generally Counterdef.’s Mot. to Dismiss Severed Claims for Forum non Conveniens and Interests of International Comity (the “Computershare 27 Motion”) [ECF No. 208]. 28 5 The Court considered the following papers: (1) the FACC; (2) the Joint Motion to Dismiss (including its attachments); (3) Opp’n to the Joint Motion -3- Case 8:17-cv-01887-JWH-JDE Document 215 Filed 03/14/22 Page 4 of 27 Page ID #:3766

1 I. BACKGROUND 2 A. Factual Summary 3 This lawsuit centers around the issuance of—and the inability to sell— 4 restricted shares of stock in Canadian cannabidiol company Alternate Health 5 Corporation. The dispute initially pit Edalat against Alternate Health 6 Corporation and its American subsidiary—Alternate Health USA, Inc. (jointly, 7 “Alternate Health”),6 but it grew to involve several more parties and 8 counterclaims. 9 Prior to the commencement of this lawsuit, Edalat and Alternate Health 10 executed several written agreements involving the business of cannabis-derived 11 nutraceuticals.7 One of those agreements was a consulting arrangement in which 12 Edalat agreed to provide consulting services to Alternate Health in exchange for 13 shares of its stock.8 Another was a licensing agreement that included patent 14 applications from Sentar.9 Alternate Health leveraged the licensing agreement, 15 in part, to raise funds from investors.10 Sentar was to receive shares of Alternate 16 Health Corporation stock in exchange for entering into that license.11 At that 17 18 19

20 (the “ Joint Motion Opposition”) [ECF No. 193]; (4) Reply to the Joint Motion Opposition (the “Joint Motion Reply”) [ECF No. 197]; (5) the Computershare 21 Motion (including its attachments); (6) Opp’n to Untimely Mot. to Dismiss on Forum Non Conveniens Grounds (the “Computershare Motion Opposition”) 22 [ECF No. 211]; and (7) Reply Mem. of Counterdef. in Supp. of the Computershare Motion (the “Computershare Motion Reply”) [ECF No. 213]. 23 6 See generally Compl. (the “Complaint”) [ECF No. 1]. 24 7 Separate Statement of Uncontroverted Facts (“SSUF”) [ECF No. 116-1] ¶¶ 6 & 7. The parties are already deeply familiar with the facts of this case, so 25 the Court recites the background only as needed. 26 8 Id. at ¶ 8. 9 Id. at ¶¶ 14 & 15. 27 10 Id. at ¶¶ 34-37. 28 11 Id. at ¶ 29. -4- Case 8:17-cv-01887-JWH-JDE Document 215 Filed 03/14/22 Page 5 of 27 Page ID #:3767

1 time, Alternate Health Corporation’s stock was publicly traded on the Canadian 2 Securities Exchange and through over-the-counter (OTC) markets.12 3 Pursuant to those two agreements, Alternate Health issued share 4 certificates to the Edalat Parties in March 2017.13 Importantly, those certificates 5 were restricted, and they bore a legend preventing their public sale before July 3, 6 2017, but the Edalat Parties understood that that restriction would eventually be 7 removed.14 8 In the summer of 2017, Alternate Health Corporation stock was trading 9 around US $2 per share, which—if the stock was sold at that price—would have 10 generated around $6 million in proceeds for the Edalat Parties.15 11 Unsurprisingly, the Edalat Parties requested the removal of the restrictive 12 legends, but Alternate Health refused.16 Edalat insists that its broker, non-party 13 Canaccord Genuity Wealth Management (USA) Inc., delivered all of the 14 required documentation for Alternate Health and Computershare to lift the 15 restriction, but to no avail.17 At the time, Computershare, a Canadian 16 corporation, was serving as Alternate Health Corporation’s appointed transfer 17 agent and registrar for its common shares.18 18 In September 2017, Computershare notified Edalat that it would not 19 remove the restrictive legends from the certificates representing his shares in 20 Alternate Health Corporation.19 The Alternate Health Parties allegedly refused 21 to authorize Computershare to remove the legends because they believed that 22

23 12 FACC ¶ 4. 13 SSUF ¶¶ 60 & 61. 24 14 Id. at ¶ 62; see also FACC ¶¶ 37 & 38. 25 15 FACC ¶ 46. 26 16 SSUF ¶¶ 63-65. 17 FACC ¶ 45. 27 18 Id. at ¶ 8. 28 19 Id. at ¶ 47. -5- Case 8:17-cv-01887-JWH-JDE Document 215 Filed 03/14/22 Page 6 of 27 Page ID #:3768

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Belize Telecom, Ltd. v. Government of Belize
528 F.3d 1298 (Eleventh Circuit, 2008)
Hilton v. Guyot
159 U.S. 113 (Supreme Court, 1895)
Gulf Oil Corp. v. Gilbert
330 U.S. 501 (Supreme Court, 1947)
Piper Aircraft Co. v. Reyno
454 U.S. 235 (Supreme Court, 1982)
American Dredging Co. v. Miller
510 U.S. 443 (Supreme Court, 1994)
F. Hoffmann-La Roche Ltd. v. Empagran S. A.
542 U.S. 155 (Supreme Court, 2004)
Quijano v. United States
93 F.3d 26 (First Circuit, 1996)
Vivendi Sa v. T-Mobile USA Inc.
586 F.3d 689 (Ninth Circuit, 2009)
Grimes v. Navigant Consulting, Inc.
185 F. Supp. 2d 906 (N.D. Illinois, 2002)
Luis Mujica v. Airscan Inc.
771 F.3d 580 (Ninth Circuit, 2014)
Ayco Farms, Inc. v. Guillermo Ochoa
862 F.3d 945 (Ninth Circuit, 2017)
Lindsay Cooper v. Tokyo Elec. Power Co. Holdings
960 F.3d 549 (Ninth Circuit, 2020)
Allington v. Forest Box & Lumber Co.
25 F.2d 141 (E.D. New York, 1928)
Lueck v. Sundstrand Corp.
236 F.3d 1137 (Ninth Circuit, 2001)
Robinson v. Stewart
17 F. App'x 573 (Ninth Circuit, 2001)
Carijano v. Occidental Petroleum Corp.
643 F.3d 1216 (Ninth Circuit, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
Alternate Health USA Inc. v. Paul Edalat, Counsel Stack Legal Research, https://law.counselstack.com/opinion/alternate-health-usa-inc-v-paul-edalat-cacd-2022.